AVACTA GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.5 GBX | -2.15% |
|
-6.76% | -60.94% |
| 05-01 | Avacta picks Christina Coughlin to replace long-serving CEO | AN |
| 04-30 | EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down | AN |
Chart calendar Avacta Group Plc
cc1e92a3b8bb.i5Po2HWj4qSrBE9-FSE38kNyKU7g4MPnJoIx2L71rKY.6uukvzLGtv7DfSZNf0YHviEZdjjXsIKPSeN-rcvB79Ld_tvvMtmywcw3JA~4286e6589e5c805ab9cef9e73ca4ee4b
Upcoming events on Avacta Group Plc
Past events on Avacta Group Plc
| 30/04/2024 12:30 | Q4 2023 Earnings Call |
| 30/04/2024 07:01 | Q4 2023 Earnings Release |
| 10/04/2024 17:30 | American Association for Cancer Research Meeting |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract Number CT188 |
| 18/03/2024 11:00 | Shareholders Meeting |
| 13/12/2023 11:00 | AVA6000 Phase Ia Data Trial Call |
| 14/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster Number: C169 |
| 12/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster number: A077 |
| 10/10/2023 | AACR-NCI-EORTC International Conference |
| 28/09/2023 11:00 | Q2 2023 Earnings Call |
| 28/09/2023 07:00 | Q2 2023 Earnings Release |
| 28/06/2023 10:30 | Annual General Meeting |
| 25/04/2023 11:00 | Q4 2022 Earnings Call |
| 25/04/2023 07:00 | Q4 2022 Earnings Release |
| 16/04/2023 18:30 | American Association for Cancer Research Meeting - Abstract Presentation Number 583 |
| 22/02/2023 | Investor Meeting - Key Opinion Leader |
| 05/11/2022 16:30 | Virtual Theranostics FAP Summit |
| 18/10/2022 | Rights Issue: 3 new shares @ 0.95 GBP for 365 existing shares |
| 28/09/2022 | Interim 2022 Earnings Release |
| 23/06/2022 15:30 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 2,76 3,00 -7.9% | 5,51 4,76 15.78% | 3,64 4,10 -11.32% | 2,94 4,50 -34.64% | 9,65 8,03 20.14% | 23,2 23,1 0.71% |
|
EBITDA Million GBP | Released Forecast Spread | -7,58 -7,48 -1.34% | -13,7 -14,1 2.54% | -14,3 -13,6 -5.07% | -26,7 -23,2 -15.12% | -23,7 -22,6 -4.54% | -20,1 -15,8 -27.67% |
|
EBIT Million GBP | Released Forecast Spread | -10,4 -9,45 -10.42% | -17,7 -17,1 -3.76% | -16,4 -16,0 -3.1% | -29,1 -25,2 -15.41% | -26,7 -25,0 -6.68% | -27,6 -24,2 -13.82% |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -10,4 -9,25 -12.32% | -18,1 -17,6 -2.58% | -21,3 -17,5 -21.96% | 0,00 0,00 - | -41,6 -25,0 -66.52% | -27,3 -33,4 18.09% |
|
Net income Million GBP | Released Forecast Spread | -8,83 -8,30 -6.37% | -15,6 -16,1 3.01% | -18,9 -15,3 -23.47% | 0,00 0,00 - | -39,2 -21,6 -81.81% | -24,9 -23,2 -7.53% |
|
EPS GBP | Released Forecast Spread | -0,13 -0,12 -11.58% | -0,13 -0,14 7.29% | 0,00 0,00 - | 0,00 0,00 - | -0,15 -0,08 -84.94% | -0,09 -0,08 -10.24% |
| Announcement Date | 02/10/18 | 06/05/20 | 22/04/21 | 06/04/22 | 25/04/23 | 30/04/24 |
Quarterly results
| Fiscal Period | December | 2022 S1 | 2022 S2 |
|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 4,14 2,10 96.95% | |
|
EBIT Million GBP | Released Forecast Spread | -14,9 | |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -32,0 -14,9 -114.71% | |
|
Net income Million GBP | Released Forecast Spread | -7,94 | |
|
EPS GBP | Released Forecast Spread | -0,03 | |
| Announcement Date | 29/09/22 | 25/04/23 |
More events
Past sector events for Avacta Group Plc
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVCT Stock
- Calendar Avacta Group Plc
